Brinker Capital Investments’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-28,675
Closed -$43.6K 1631
2022
Q4
$43.6K Sell
28,675
-126
-0.4% -$217 ﹤0.01% 1335
2022
Q3
$61K Sell
28,801
-129
-0.4% -$272 ﹤0.01% 1311
2022
Q2
$39K Buy
+28,930
New +$42.9K ﹤0.01% 1340

Other funds holding PGEN

Brinker Capital Investments's PGEN Position: Q1 2023 in Review

Brinker Capital Investments sold out of Precigen (PGEN) in Q1 2023, closing a stake of 28,675 shares — an estimated $43.6K sold.

Brinker Capital Investments first reported a position in PGEN in Q2 2022 and held it in 3 quarters. The position peaked at $61K in Q3 2022. 157 funds tracked by Wall St. Rank hold PGEN as of Q1 2023.

  • Brinker Capital Investments reported no remaining Precigen position as of Q1 2023 after selling out during the quarter.
  • Brinker Capital Investments sold 28,675 Precigen shares in Q1 2023, an estimated $43.6K.
  • Brinker Capital Investments first reported a position in Precigen in Q2 2022 and held it in 3 quarters.
  • Brinker Capital Investments's Precigen position peaked at $61K in Q3 2022.
  • 157 funds tracked by Wall St. Rank held Precigen as of Q1 2023.

Based on Brinker Capital Investments's 13F filing for Q1 2023, filed 31 Jul 2025.